Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1020621Generated: October 25, 2026

4-(6-(Trifluoromethyl)pyridazin-3-yl)pyridin-2(1H)-one → tert-Butyl 7-(2-oxo-4-(6-(trifluoromethyl)pyridazin-3-yl)pyridin-1(2H)-yl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate

https://huagongshe.com/reaction/1020621

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-(6-(Trifluoromethyl)pyridazin-3-yl)pyridin-2(1H)-oneHCID 57950262—
Reactanttert-Butyl 7-bromo-5-(triisopropylsilyl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylateHCID 57950390—
Producttert-Butyl 7-(2-oxo-4-(6-(trifluoromethyl)pyridazin-3-yl)pyridin-1(2H)-yl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylateHCID 5795044930.7%

Reaction Steps

tert-Butyl 7-bromo-5-(triisopropylsilyl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate (260 mg, 0.51 mmol) and 4-(6-(trifluoromethyl)pyridazin-3-yl)pyridin-2(1H)-one (123 mg, 0.510 mmol) were reacted according to the procedure of Example 30 (step g) to provide the title compound (80 mg, 30%) as a yellow solid: ESI MS m/z 512 [M+H]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08716308B2
Source datasetuspto-grants-2014_05
ORD IDord-5bd9c40189c547808297ebf28df04d02
Source noteuspto-grants-2014_05